This Ollie's Bargain Outlet Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Comments
Loading...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Piper Sandler analyst David Amsellem downgraded Amphastar Pharmaceuticals, Inc. AMPH from Overweight to Neutral and lowered the price target from $66 to $36. Amphastar Pharma shares closed at $33.39 on Monday. See how other analysts view this stock.
  • Baird analyst Peter Arment downgraded Triumph Group, Inc. TGI from Outperform to Neutral but raised the price target from $20 to $26. Triumph Group shares closed at $25.10 on Monday. See how other analysts view this stock.
  • Jefferies analyst Randal Konik downgraded the rating for Ollie’s Bargain Outlet Holdings, Inc. OLLI from Buy to Hold and lowered the price target from $125 to $111. Ollie’s Bargain shares closed at $107.63 on Monday. See how other analysts view this stock.
  • UBS analyst Manav Gupta downgraded Calumet, Inc. CLMT from Neutral to Sell and cut the price target from $20.5 to $15. Calumet shares closed at $18.34 on Monday. See how other analysts view this stock.
  • Wolfe Research analyst Trevor Allinson downgraded the rating for American Woodmark Corporation AMWD from Outperform to Peer Perform. American Woodmark shares closed at $75.65 on Monday. See how other analysts view this stock.

Considering buying OLLI stock? Here’s what analysts think:

Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!